Optimizing approaches for targeted integration of transgenic cassettes by integrase-mediated cassette exchange in mouse and human stem cells
To enable robust expression of transgenes in stem cells, recombinase-mediated cassette exchange at safe harbor loci is frequently adopted. The choice of recombinase enzyme is a critical parameter to ensure maximum efficiency and accuracy of the integration event. We have explored the serine recombinase family of site-specific integrases and have directly compared the efficiency of PhiC31, W-beta, and Bxb1 integrase for targeted transgene integration at the Gt(ROSA)26Sor locus in mouse embryonic stem cells. All 3 integrases were found to be suitable for efficient engineering and long-term expression of each integrase was compatible with pluripotency, as evidenced by germline transmission. Bxb1 integrase was found to be 2-3 times more efficient than PhiC31 and W-beta. The Bxb1 system was adapted for cassette exchange at the AAVS1 locus in human induced pluripotent stem (iPS) cells, and the 2 commonly used ubiquitous promoters, CAG and Ef1α (EIF1A), were tested for their suitability in driving expression of the integrated transgenic cargo. AAVS1-integrated Ef1α promoter led to a very mosaic pattern of expression in targeted hiPS cells, whereas the AAVS1-integrated CAG promoter drove consistent and stable expression. To validate the system for the integration of functional machinery, the Bxb1 integrase system was used to integrate CAG-driven CRISPR-activation and CRISPR-inhibition machinery in human iPS cells and robust sgRNA-induced up- and downregulation of target genes was demonstrated.
Authors
- Arnaud Bolard
- Marta Perez‐Alcantara (ORCID: https://orcid.org/0000-0002-7767-1940)
- Rebeca Diaz (ORCID: https://orcid.org/0000-0003-0937-5928)
- Nicola L. Beer (ORCID: https://orcid.org/0000-0002-4964-7150)
- Benjamin Davies (ORCID: https://orcid.org/0000-0003-3623-600X)
- Phalguni Rath (ORCID: https://orcid.org/0009-0008-1099-8966)
- Nicole Hortin (ORCID: https://orcid.org/0000-0002-0157-1468)
- Mark I. McCarthy (ORCID: https://orcid.org/0000-0002-4393-0510)
- Xiang Li (ORCID: https://orcid.org/0000-0001-6222-4446)
- Philipp Krämer
- Daniel Biggs
- Chris Preece
Institutions
- Centre for Human Genetics (GB)
- The Francis Crick Institute (GB)
- University of Oxford (GB)
Publication Details
- Journal
- Stem Cells
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1093/stmcls/sxae092
- Citations
- 3
- Primary Topic
- CRISPR and Genetic Engineering
- Type
- article
- Field-Weighted Citation Impact
- 2.42
Funders
- Wellcome Trust
- Francis Crick Institute
- Cancer Research UK
- European Commission
- Medical Research Council